Apneic Oxygenation Including Precipitous Intubations During RSI in the ED (RAPID)

March 22, 2020 updated by: Ilya Ostrovsky, MD, Rutgers, The State University of New Jersey

Randomized Controlled Trial of Apneic Oxygenation Including Precipitous Intubations During RSI in the Emergency Department

This RCT is testing the efficacy of apneic oxygenation during endotracheal intubation in the emergency department. Currently the standard practice in the ED when performing endotracheal intubation is that some providers use apneic oxygenation (the application of a nasal cannula at 15LPM) throughout the intubation procedure, while others do not apply apneic oxygenation. Initial literature in the operating room showed that apneic oxygenation helps prevent desaturation during the procedure. However, the latest literature conducted in critical care settings (one study in the ICU and one in the ED) questions the efficacy of this intervention in critically ill patients; however, no harm has been shown. Our study aims to test this intervention further by adding in a special subset of patients that was excluded from prior studies, precipitous intubations, or those patients that have to be intubated quickly and cannot have adequate pre-oxygenation. We hypothesize that apneic oxygenation will be more efficacious in this subset than in the overall ED population. We will randomize patients requiring endotracheal intubation into intervention (apneic oxygenation) and control (no apneic oxygenation). We will measure the lowest arterial oxygen saturation from the start of the intubation procedure through 2 minutes after intubation is complete.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Newark, New Jersey, United States, 07103
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The inclusion criteria for our study will include patients 18 years or older who require emergent endotracheal intubation utilizing rapid sequence intubation (RSI) in the Emergency Department with first attempt taken by a resident or attending physician working in the emergency department. This includes Emergency Medicine attending physicians and residents as well as non-Emergency Medicine rotators (e.g.., Internal Medicine residents who are rotating through the Emergency Department).

Exclusion Criteria:

  • Exclusion criteria include patients who are in cardiac arrest, or if the patient received any positive pressure ventilation (i.e, BPAP, CPAP, BVM) in the emergency department before RSI.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Apneic Oxygenation
Participants receiving apneic oxygenation
Providing oxygenation through nasal cannula during the apneic phase of endotracheal intubation.
No Intervention: No Apneic Oxygenation
Participants not receiving apneic oxygenation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lowest oxygen saturation overall
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
Lowest oxygen saturation between overall control and intervention groups
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lowest oxygen saturation precipitous intubations
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
Lowest oxygen saturation between control and intervention groups that did not receive adequate pre-oxygenation only
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
Lowest oxygen saturation pre-oxygenation
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
Lowest oxygen saturation between control and intervention groups that did receive
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
Difference in baseline and final oxygen saturation
Time Frame: Decision to intubate through 2 minutes after completion of endotracheal intubation
Decision to intubate through 2 minutes after completion of endotracheal intubation
Difference in oxygen saturation before and after apneic period
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
Desaturation
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
The proportion of patients who desaturate below 90%
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
number of attempts
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
number of times laryngoscope is placed into the mouth in an attempt to pass an endotracheal tube
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
Need for second operator
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
A second physician had to attempt intubation
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
Need for additional intubating equipment
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
The operator needed to change or add equipment to facilitate intubation
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
Esophageal intubations
Time Frame: From first attempt at intubation through entire ED stay, approximately 6 hours.
The proportion of intubations that resulted in the endotracheal tube being placed in the esophagus
From first attempt at intubation through entire ED stay, approximately 6 hours.
Procedural hypotension
Time Frame: Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
Proportion of became hypotensive at any point during the intubation procedure
Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
Aspiration
Time Frame: Within 24 hours after intubation procedure was complete
Proportion of patients that had evidence of aspiration
Within 24 hours after intubation procedure was complete
Hospital length of stay
Time Frame: Up to 28 days after intubation
Number of days patient is hospitalized
Up to 28 days after intubation
Number of days intubated
Time Frame: Up to 28 days after intubation
Up to 28 days after intubation
In-hospital mortality
Time Frame: Up to 28 days after intubation
Up to 28 days after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ilya Ostrovsky, MD, Rutgers, The State University of New Jersey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

March 22, 2020

Study Completion (Actual)

March 22, 2020

Study Registration Dates

First Submitted

September 11, 2018

First Submitted That Met QC Criteria

October 1, 2018

First Posted (Actual)

October 3, 2018

Study Record Updates

Last Update Posted (Actual)

March 25, 2020

Last Update Submitted That Met QC Criteria

March 22, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe